Oral contraceptive agents and breast cancer

A population-based case-control study

Thomas E. Rohan, A. J. McMichael

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In this population-based case-control study that was conducted in Adelaide, South Australia, and which involved 395 case subjects and 386 control subjects who were aged 20 years to 69 years, the adjusted relative risk of breast cancer for women who had ever used oral contraceptive agents was 1.06 (95% confidence interval [CI], 0.70-1.60). Relative risks that were associated with use of oral contraceptive agents for one months to 18 months and for 19 months or more before a first pregnancy were 1.09 (95% CI, 0.45-2.62) and 1.67 (95% CI, 0.63-4.42), respectively, but the trend was not statistically significant. Relatively-little varation in risk was found in association with the total duration of the use of oral contraceptive agents and with years since the first and the last use or oral contraceptive agents. When the risk of breast cancer in association with the use of oral contraceptive agents was examined across levels of risk factors of breast cancer (history of benign breast disease, family history of breast cancer and parity), the only relative risk which deviated markedly from unity was that which was associated with use of oral contraceptive agents in women with a history of benign breast disease; however, the relative risk of 1.77 (95% CI, 0.35-8.97) was not statistically significant. In conclusion, the results of this study support those of the majority of previous studies in showing no overall relationship between the use of oral contraceptive agents and the risk of breast cancer.

Original languageEnglish (US)
Pages (from-to)520-526
Number of pages7
JournalMedical Journal of Australia
Volume149
Issue number10
StatePublished - 1988
Externally publishedYes

Fingerprint

Oral Contraceptives
Contraceptive Agents
Case-Control Studies
Breast Neoplasms
Population
Confidence Intervals
Breast Diseases
South Australia
Parity
Pregnancy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Oral contraceptive agents and breast cancer : A population-based case-control study. / Rohan, Thomas E.; McMichael, A. J.

In: Medical Journal of Australia, Vol. 149, No. 10, 1988, p. 520-526.

Research output: Contribution to journalArticle

@article{5f9a7a4c0c684e639f14894c69e1246f,
title = "Oral contraceptive agents and breast cancer: A population-based case-control study",
abstract = "In this population-based case-control study that was conducted in Adelaide, South Australia, and which involved 395 case subjects and 386 control subjects who were aged 20 years to 69 years, the adjusted relative risk of breast cancer for women who had ever used oral contraceptive agents was 1.06 (95{\%} confidence interval [CI], 0.70-1.60). Relative risks that were associated with use of oral contraceptive agents for one months to 18 months and for 19 months or more before a first pregnancy were 1.09 (95{\%} CI, 0.45-2.62) and 1.67 (95{\%} CI, 0.63-4.42), respectively, but the trend was not statistically significant. Relatively-little varation in risk was found in association with the total duration of the use of oral contraceptive agents and with years since the first and the last use or oral contraceptive agents. When the risk of breast cancer in association with the use of oral contraceptive agents was examined across levels of risk factors of breast cancer (history of benign breast disease, family history of breast cancer and parity), the only relative risk which deviated markedly from unity was that which was associated with use of oral contraceptive agents in women with a history of benign breast disease; however, the relative risk of 1.77 (95{\%} CI, 0.35-8.97) was not statistically significant. In conclusion, the results of this study support those of the majority of previous studies in showing no overall relationship between the use of oral contraceptive agents and the risk of breast cancer.",
author = "Rohan, {Thomas E.} and McMichael, {A. J.}",
year = "1988",
language = "English (US)",
volume = "149",
pages = "520--526",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Co. Ltd",
number = "10",

}

TY - JOUR

T1 - Oral contraceptive agents and breast cancer

T2 - A population-based case-control study

AU - Rohan, Thomas E.

AU - McMichael, A. J.

PY - 1988

Y1 - 1988

N2 - In this population-based case-control study that was conducted in Adelaide, South Australia, and which involved 395 case subjects and 386 control subjects who were aged 20 years to 69 years, the adjusted relative risk of breast cancer for women who had ever used oral contraceptive agents was 1.06 (95% confidence interval [CI], 0.70-1.60). Relative risks that were associated with use of oral contraceptive agents for one months to 18 months and for 19 months or more before a first pregnancy were 1.09 (95% CI, 0.45-2.62) and 1.67 (95% CI, 0.63-4.42), respectively, but the trend was not statistically significant. Relatively-little varation in risk was found in association with the total duration of the use of oral contraceptive agents and with years since the first and the last use or oral contraceptive agents. When the risk of breast cancer in association with the use of oral contraceptive agents was examined across levels of risk factors of breast cancer (history of benign breast disease, family history of breast cancer and parity), the only relative risk which deviated markedly from unity was that which was associated with use of oral contraceptive agents in women with a history of benign breast disease; however, the relative risk of 1.77 (95% CI, 0.35-8.97) was not statistically significant. In conclusion, the results of this study support those of the majority of previous studies in showing no overall relationship between the use of oral contraceptive agents and the risk of breast cancer.

AB - In this population-based case-control study that was conducted in Adelaide, South Australia, and which involved 395 case subjects and 386 control subjects who were aged 20 years to 69 years, the adjusted relative risk of breast cancer for women who had ever used oral contraceptive agents was 1.06 (95% confidence interval [CI], 0.70-1.60). Relative risks that were associated with use of oral contraceptive agents for one months to 18 months and for 19 months or more before a first pregnancy were 1.09 (95% CI, 0.45-2.62) and 1.67 (95% CI, 0.63-4.42), respectively, but the trend was not statistically significant. Relatively-little varation in risk was found in association with the total duration of the use of oral contraceptive agents and with years since the first and the last use or oral contraceptive agents. When the risk of breast cancer in association with the use of oral contraceptive agents was examined across levels of risk factors of breast cancer (history of benign breast disease, family history of breast cancer and parity), the only relative risk which deviated markedly from unity was that which was associated with use of oral contraceptive agents in women with a history of benign breast disease; however, the relative risk of 1.77 (95% CI, 0.35-8.97) was not statistically significant. In conclusion, the results of this study support those of the majority of previous studies in showing no overall relationship between the use of oral contraceptive agents and the risk of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0024203725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024203725&partnerID=8YFLogxK

M3 - Article

VL - 149

SP - 520

EP - 526

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 10

ER -